You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,919,832


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,919,832
Title: Amine polymer sequestrant and method of cholesterol depletion
Abstract:An amine polymer includes first and second substituents bound to amines of the polymer. The first substituent includes a hydrophobic moiety. The second substituent includes a quaternary amine-containing moiety. A method for binding bile salts of bile acids in a mammal includes orally administering to the mammal a therapeutically-effective amount of the amine polymer.
Inventor(s): Mandeville, III; W. Harry (Lynnfield, MA), Holmes-Farley; Stephen Randall (Arlington, MA)
Assignee: Geltex Pharmaceuticals Inc. (Waltham, MA)
Application Number:08/779,779
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,919,832

Introduction

United States Patent 5,919,832, titled "Polymeric Amine Salts," is a patent that has significant implications in the field of polymer chemistry and pharmaceuticals. To understand its impact and the protection it offers, it is crucial to delve into the scope and claims of the patent, as well as its position within the broader patent landscape.

Patent Overview

Title and Inventors: The patent, "Polymeric Amine Salts," was invented by Mandeville, III et al. and assigned to Genzyme Corp.

Priority Date and Grant Date: The priority date for this patent is June 10, 1994, and it was granted on July 6, 1999[2].

Claim Scope

Importance of Claim Scope

The claim scope in a patent application is critical as it defines the boundaries of the invention and the protection it receives. A well-crafted claim scope must balance breadth and specificity to ensure robust protection without being overly broad or too narrow[5].

Claims of US 5,919,832

The patent includes multiple claims that describe the polymeric amine salts, their composition, and their methods of preparation. Here are some key aspects of the claims:

  • Composition Claims: These claims describe the chemical structure and composition of the polymeric amine salts, including the types of monomers and the polymerization process.
  • Method Claims: These claims outline the methods for preparing the polymeric amine salts, including the use of specific initiators and reaction conditions.
  • Use Claims: These claims may include the intended uses of the polymeric amine salts, such as in pharmaceutical applications or as bile salt sequestrants.

Claim Analysis

Claim Coverage Matrix

To analyze the claims of US 5,919,832 effectively, a Claim Coverage Matrix can be used. This matrix categorizes the claims by their scope concepts, allowing for a comprehensive understanding of which claims protect which aspects of the invention. This approach helps in identifying gaps in coverage and potential future design opportunities[3].

Claim Charts

Using Claim Charts, which are interactive and generated by software like ClaimScape®, technical experts can review the claims to determine their applicability to target products or methods. This tool is particularly useful for identifying whether the scope concepts of the patent claims align with the company's current and future technological directions[3].

Patent Landscape

Related Patents

The patent landscape surrounding US 5,919,832 includes several related patents that cover similar or complementary technologies. For example:

  • US 6,083,495: This patent, also by Mandeville, III et al., covers additional aspects of polymeric amine salts and their preparation methods.
  • US 6,423,754: Another patent by the same inventors, this one focuses on different applications and formulations of polymeric amine salts[4].

Prior Art and Future Directions

Understanding the prior art in the field is crucial for assessing the novelty and non-obviousness of the claims in US 5,919,832. The patent's specification and claims must be anchored to the disclosed embodiments to avoid invalidation risks such as the abstract idea exception or failure to meet the written description requirement[5].

Obviousness-Type Double Patenting (ODP)

In the context of patent families and continuations, ODP is an important consideration. The Federal Circuit has ruled that ODP analyses must consider the expiration dates of patents, including any adjustments due to Patent Term Adjustments (PTA) or Patent Term Extensions (PTE)[1].

Practical Implications

Enforcement and Licensing

The scope and claims of US 5,919,832 are critical for enforcement and licensing strategies. A clear understanding of what is protected allows the patent holder to identify potential infringers and negotiate licensing agreements effectively.

Research and Development

For companies involved in research and development, understanding the claims of US 5,919,832 helps in navigating the patent landscape to avoid infringement and identify areas for innovation that are not already protected.

Key Takeaways

  • Balanced Claim Scope: The claims of US 5,919,832 must strike a balance between breadth and specificity to ensure robust protection.
  • Comprehensive Analysis: Using tools like Claim Coverage Matrices and Claim Charts is essential for a thorough analysis of the patent's scope.
  • Patent Landscape: Understanding related patents and prior art is crucial for assessing the patent's validity and potential for future innovation.
  • ODP Considerations: The expiration dates and any adjustments due to PTA or PTE must be considered to avoid ODP issues.

FAQs

  1. What is the significance of the priority date in a patent application? The priority date is the earliest date from which the patent term is calculated and is crucial for determining the novelty and non-obviousness of the invention.

  2. How do Claim Coverage Matrices help in patent analysis? Claim Coverage Matrices categorize claims by scope concepts, helping to identify gaps in coverage and potential future design opportunities.

  3. What are the risks of having overly broad claims in a patent application? Overly broad claims are more difficult to get granted and are easier to invalidate due to grounds such as the abstract idea exception or failure to meet the written description requirement.

  4. How does Obviousness-Type Double Patenting (ODP) affect patent validity? ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a prior patent, ensuring that the patent term is not extended beyond what is legally permissible.

  5. Why is it important to analyze related patents in the patent landscape? Analyzing related patents helps in understanding the broader technological context, identifying potential infringement risks, and finding opportunities for innovation that are not already protected.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,919,832

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,919,832

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0764174 ⤷  Subscribe 91100 Luxembourg ⤷  Subscribe
European Patent Office 0764174 ⤷  Subscribe 300159 Netherlands ⤷  Subscribe
European Patent Office 0764174 ⤷  Subscribe CA 2004 00027 Denmark ⤷  Subscribe
European Patent Office 0764174 ⤷  Subscribe SPC/GB04/031 United Kingdom ⤷  Subscribe
European Patent Office 0764174 ⤷  Subscribe SPC013/2004 Ireland ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.